Single dose nonavalent HPV vaccine – need of the hour

Authors

  • Soma Bandyopadhyay
  • Manidip Pal College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal. India

DOI:

https://doi.org/10.3126/nje.v10i2.28962

Keywords:

HPV, Nonavalent, Quadrivalent, Single dose, Vaccine

Abstract

HPV vaccination of the 9-14 years girl children is the answer to eradicate carcinoma cervix. Nonavalent vaccine provides wider coverage than the quadrivalent vaccine. On long-term follow-up, even after single dose HPV vaccination, antibody titre remains good. Herd immunity also achieved by HPV vaccine. Hence single dose nonavalent HPV vaccination of mass people (sexually naive 9-14 years girl children) can provide almost 100% protections and this will be cost-effective also for developing country.  

Downloads

Download data is not yet available.
Abstract
329
PDF
321

Author Biographies

Soma Bandyopadhyay

(Formerly) Associate Professor, Department of Obstetrics & Gynecology, G.S.L.Medical College & General Hospital, NH-5, Lakshmipuram, Rajahmundry, Andhrapradesh

Manidip Pal, College of Medicine & JNM Hospital, WBUHS, Kalyani, Nadia, West Bengal. India

Professor & HOD,

Department of Obstetrics & Gynecology

College of Medicine & JNM Hospital, WBUHS,

Kalyani, Nadia, West Bengal. India

email address: manideep2b@yahoo.com

Downloads

Published

2020-06-30

How to Cite

Bandyopadhyay, S., & Pal, M. (2020). Single dose nonavalent HPV vaccine – need of the hour. Nepal Journal of Epidemiology, 10(2), 871–873. https://doi.org/10.3126/nje.v10i2.28962

Issue

Section

Short Communications